Nature Debuts Peer-Review Option

Authors submitting to Nature journals can soon request double-blind reviews.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, PETE O'SHEABeginning next month, authors submitting their work to Nature and its associated journals can request double-blind peer review, in which the authors’ names and affiliations will be withheld from reviewers (much like reviewers’ names and affiliations are currently withheld from the authors).

“Advocates of double-blind peer review suggest that it eliminates personal biases, such as those based on gender, seniority, reputation and affiliation,” Nature noted in its February 18 announcement.

In contrast, some researchers have advocated for open peer review, in which the authors and reviewers both are clearly identified, arguing that such increased transparency might further limit bias. But some open-peer-review advocates, such as PhD student Matthew Evans of the John Innes Centre in Norwich, U.K., suggest that, if reviews are to be blinded, double-blind is preferable to single-blind peer review.

“Good scientists will continue to publish good papers in good journals under a double-blind peer review system,” wrote Boyan Garvalov of Justus Liebig University Giessen, Germany, in a January Advances in Regenerative Biology article (hat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies